Liangfang Shen
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- NF-κB Signaling Pathways 6
- Oncology top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 6
- Melanoma and MAPK Pathways 5
- Otorhinolaryngology top 10%
- Genetics top 10%
- Glioma Diagnosis and Treatment 6
-
- Ferroptosis and cancer prognosis 7
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Liangfang Shen
76 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 598
- Oncology 390
- Molecular Biology 946
- Otorhinolaryngology 45
- Genetics 94
Countries citing papers authored by Liangfang Shen
This map shows the geographic impact of Liangfang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangfang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangfang Shen more than expected).
Fields of papers citing papers by Liangfang Shen
This network shows the impact of papers produced by Liangfang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangfang Shen. The network helps show where Liangfang Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liangfang Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 26 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 14 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 6 | |
| 17 | 2018 | 13 | |
| 18 | 2016 | 33 | |
| 19 | 2012 | 9 | |
| 20 | 2011 | 25 |
About Liangfang Shen
Liangfang Shen is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 77 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Ferroptosis and cancer prognosis (7 papers), Glioma Diagnosis and Treatment (6 papers), NF-κB Signaling Pathways (6 papers), Epigenetics and DNA Methylation (6 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (390 citations) and Molecular Biology (946 citations). Liangfang Shen has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Xinqiong Huang, Jun Fu, Lin Shen, Fujun Li, Junwen Yang, Yanyan Li, Chaojun Duan, Xiaoxue Xie, Zhanzhan Li and Yan Xu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.